TCT-175 Temporal Changes in Clinicopathologic Features of Ischemic Cardiac Rupture  by El Sabbagh, Abdallah et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5 B65deployment of the stent and uncovered plaque remains the main
cause of SST.
CATEGORIES CORONARY: Acute Coronary Syndromes
KEYWORDS ST- Stent Thrombosis
TCT-174
Baseline hemoglobin level, anemia and adverse events in patients with
acute coronary syndromes; Lessons from ACUITY and HORIZONS-AMI
Sorin Brener,1 Roxana Mehran,2 Girma M. Ayele,3 Gregg W. Stone4
1New York Methodist Hospital, Brooklyn, NY; 2Icahn School of
Medicine at Mount Sinai, New York, United States; 3Cardiovascular
Research Foundation, New York, NY; 4Columbia University Medical
Center and the Cardiovascular Research Foundation, New York, United
States
BACKGROUND The association between anemia at admission and
adverse outcome in patients with acute coronary syndromes (ACS) has
been recently emphasized. A more granular analysis between baseline
hemoglobin and adverse events has not been reported.
METHODS Anemia was deﬁned as serum hemoglobin <12 g/dl in
women and <13 g/dl in men in two large ACS trials – ACUITY and
HORIZONS-AMI. We plotted gender–speciﬁc hazard functions for all-
cause mortality at 1 year and major bleeding at 30 days according to
baseline hemoglobin, and analyzed time to events according to ter-
tiles of hemoglobin.
RESULTS Among 16,421 patients, 2,558 (15.6%) had anemia at base-
line. Patients with anemia were older, more often women, and had
higher rates of CAD risk factors. They were also signiﬁcantly more
likely not to undergo revascularization. The hemoglobin level on
admission was 11.71.0 g/dl in anemic and 14.61.2 g/dl in non-
anemic patients (P<0.001). The incidence of ischemic events in the
two groups is shown in Table 1. Death and MI were signiﬁcantly more
common in anemic patients at 30 days and at 1 year, while rates of ST,
TLR and TVR were similar. Non-CABG major bleeding was 2x as
common in the anemic patients (8.4% vs. 3.6%, P<0.001), and
transfusions were administered 5x more often (7.5% vs. 1.5%,
P<0.001). Patients in the highest tertile of hemoglobin (>14.8 g/dl)
has the lowest 1-year mortality, compared with the middle tertile
(13.5-14.8 g/dl) and lowest tertile (<13.5 g/dl): 3.0% vs. 3.4% vs.
5.8%, P<0.0001, respectively. There was no signiﬁcant difference
between the middle and highest tertile of baseline hemoglobin
(P¼0.08). Gender-speciﬁc spline transformations of the hazard for
death at 1 year as a function of hemoglobin level on admission
showed that the lowest mortality was observed at a baseline
hemoglobin level of 14.6 g/dl for men and 13.2 g/dl for women.
Below and above these levels mortality increased (U-shaped curve).
The lowest rate of major bleeding events occurred at similar
hemoglobin levels as for mortality.
CONCLUSIONS Baseline hemoglobin carries important prognostic
information and appears to have a non-linear association with both
death and major bleeding events. The risk for mortality and major
bleeding increases with hemoglobin levels below and above 14.6 g/dl
for men and 13.2 g/dl for women.Anemia No Anemia p value30 DAY EVENTSDeath 3.1% (78) 1.5% (203) <0.0001Reinfarction 5.5% (139) 4.3% (593) 0.008Death or reinfarction 7.9% (201) 5.5% (757) <0.0001Deﬁnite stent
thrombosis0.4% (11) 0.8% (103) 0.08Target vessel
revascularization1.2% (30) 1.6% (221) 0.111-YEAR EVENTSDeath 7.4% (184) 3.5% (442) <0.0001Reinfarction 8.5% (203) 6.4% (857) 0.0005Death or reinfarction 14.7% (359) 9.2% (1212) <0.0001Deﬁnite stent
thrombosis0.8% (19) 1.2% (156) 0.09Target vessel
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BACKGROUND The temporal changes in the clinicopathological
characteristics of cardiac rupture (CR) are ill-deﬁned.
METHODS 187 consecutive decedents with acute myocardial infarc-
tion (AMI) and fatal CR of the left ventricular free wall and/or septum
whose autopsies were performed at Mayo Clinic between 1986 and
2012 were included and their clinical and autopsy characteristics were
studied. Overall autopsies were divided into three groups: group 1
(N¼100) (1986-1995); (N¼49) group 2, (1996-2004); and group 3 (N¼38)
(2005-2012).
RESULTS Median age of decedents at CR did not change from be-
tween the 3 groups (76, 76, 72; p¼0.35), however, the prevalence of
hypertension and prior MI decreased with time. The most common
clinical and anatomical site of CR in groups 2 and 3 were at the edge of
an inferolateral infarct (Fig 1). Median infarct age remained the same
(Table 1). Plaque rupture was seen less commonly, however, severe
atherosclerosis was more prevalent in groups 2 and 3.
Table 1VariableGroup 1
(N[100)Group 2
(N[49)Group 3
(N[38) PAge, median 76 76 72 0.35Men 49% 55% 53% 0.77Hypertension 72% 65% 50% 0.12Diabetes 21% 31% 21% 0.53Smoking history 31% 56 55% 0.026Prior MI 22% 15% 0 0.07Presentation with chest pain 75% 77% 40% 0.0073 vessels with Grade 4 atherosclerosis 29% 43% 51% 0.035Plaque rupture not seen 19% 48% 74% <0.001Acute thrombus 80% 70% 66% 0.21Infarct site0.14
- Anterior 45% 33% 26%- Inferior 35% 41% 37%- Lateral 19% 27% 37%Median infarct age, days 4 3.5 4 0.08Rupture Site with Infarct0.52Central 32% 43% 42%Peripheral 65% 57% 58%
B66 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5CONCLUSIONS CR was seen more commonly in elderly men at pe-
riphery of inferolateral location 4 days after AMI in recent groups.
Plaque rupture is less common; however, severe three vessel coronary
artery disease is seen more frequently.
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BACKGROUND To compare the long-term clinical outcomes of staged
percutaneous coronary intervention (PCI) and “one-time” PCI in pa-
tients with non–ST-segment elevation acute coronary syndromes
(NSTE-ACS) and multivessel coronary disease (MVD).
METHODS From 2009 to 2012, a total of 1414 consecutive NSTE-ACS pa-
tients that underwent PCI of culprit and nonculprit lesions for multivessel
disease in General Hospital of Shenyang Military Region were prospec-
tively registered. Patients received “one-time” PCI (n¼822) or staged PCI
(n¼592) according to physician’s discretion. The primary outcomewas the
composite of cardiac death or myocardial infarction (MI).
RESULTS Baseline and angiographic characteristics showed staged
patients had a worse clinical presentation. The estimated 3-year
composite rate of cardiac death or MI was 6.2% for staged PCI, 6.8%
for “one-time” PCI (log-rank test: p¼0.536). At multivariate analysis,
staged PCI was an independent predictor of cardiac death or MI
(hazards ratio [HR]:0.581, 95% conﬁdence interval [CI]:0.356–0.948,
p¼0.022). In a propensity score matched cohort, staged PCI was
associated with a signiﬁcantly lower risk of cardiac death or MI
compared to “one-time” PCI (4.5% vs 8.8%, HR 0.466, 95% CI: 0.247–
0.879, p¼0.016). Subgroup analysis suggested staged PCI might be
considered in patients with high risk such as old age, renal dysfunc-
tion, diabetes mellitus, previous MI or high GRACE risk score.
CONCLUSIONS Staged PCI is optimal revascularization strategy for
patients with NSTE-ACS, especially high-risk patients, with a lower
composite of cardiac death or MI compared to “one-time” PCI. Ran-
domized-control trial was needed to conﬁrm this result.
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BACKGROUND The percutaneous treatment of the obstructive
atherosclerotic disease in coronary saphenous bypass grafts remains a
challenge in interventional cardiology. Treatment of degeneratedsaphenous vein grafts still involves a high risk of immediate embolic
complications, high incidence of target lesion revascularization and
progression of the disease on adjacent segments and often difﬁculty
in the evaluation of the caliber and discrepancy in size in presence of
aneurysm. Aim: to evaluate if the use of self-expandable stents may
offer an advantage compared to balloon-expandable stents.
METHODS Self-expandable stents may solve the problem of the
discrepancy in size, they can be used in presence of aneurysms or of
widespread disease of the graft implying a lower risk of malapposition,
with less acute thrombosis. They don’t require a heavy post-dilatation
implying a lower risk of thromboembolism and parietal damage and
leading to a reduced risk of in-stent restenosis, edge- restenosis and
deterioration of adjacent segments. At this purpose we adopted the “Soft
touch technique” which consists in direct stenting (if possible) and
postdilatation limited to the most stenotic portion of the graft using
undersized balloons (ratio balloon /vessel diameter: 0,8). Self expand-
able stents increase in diameter in the days following the procedure, this
may reduce the incidence of plaque rupture and distal embolization.
RESULTS Between October 2012 and May 2015 we treated 25 patients.
16 patients presented with acute coronary syndrome with evidence of
soft plaque and intraluminal thrombosis. Mean age of the grafts: 12
years (4-21 years). In 10 cases we used a distal embolic protection
ﬁlter. 8 patients had aneurysmatic dilatation of the graft (maximum
diameter of the vessels between 6 and 7 mm). No major complications
occurred. In one case we implanted a balloon expandable stent at
distal edge of self-expandable stent for distal dissection of the vessel
with a good ﬁnal result. In one case we experienced an in-stent
restenosis due to distortion of the stent struts caused by the guiding
catheter, this ostial lesion was treated successfully with a balloon-
expandable stent implantation. Good angiographic result in all cases
(ﬁnal TIMI ﬂow III). Cardiovascular computed tomography performed
after 3 months conﬁrmed the patency of the stents. All patients
remained asymptomatic during follow-up.
CONCLUSIONS The treatment of degenerated coronary saphenous
vein grafts with self-expandable stents and “soft touch technique”,
being less aggressive on the graft, may reduce the risk of distal
embolization and therefore of periprocedural infarction. This tech-
nique, implying a minor parietal trauma, may also reduce the inci-
dence of restenosis and solve the problem of mismatch of caliber and
widespread disease preventing the implantation of additional stents.
Larger and appropriate studies are needed to determine differences,
optimize clinical practice and validate our hypothesis.
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BACKGROUND Spontaneous coronary artery dissection (SCAD) is an
unusual cause of acute coronary syndrome. Although the prognosis is
good the management is not well established. Our purpose was to
describe the clinical presentation, management and long term-out-
comes of a retrospective cohort with SCAD.
METHODS A total of 37 patients registered in our institution from
2000 to 2014 were retrospectively studied. The deﬁnition of SCAD was
based on the presence of medial dissection or intramural hematoma
that was recognized by angiography and according with the classiﬁ-
cation proposed by Saw.
RESULTS 37 patients diagnosed as SCAD (male/female 15/22, age
5412 [SD] years) were included in the analysis. The clinical presen-
tation was myocardial infarction in 86.5% of patients. SCAD devel-
oped after physical or emotional stress in 4 patients (10%) and 7
patients (20%) had hypothyroidism. The left anterior descending ar-
tery was involved in 22 patients (60%) and left main was involved in 1
patient. 5 patients had multi-vessel SCAD (13.5%). Recurrences of
SCAD were shown in 2 patients (5%). According to the classiﬁcation
proposed by Saw 21 patients (57%) had type 1 dissection (evident
arterial wall stain), 11 patients (30%) had type 2 (diffuse stenosis of
varying severity) and 5 of them (13%) had type 3 (mimic atheroscle-
rosis) dissection. Coronary artery tortuosity was present in 17 patients
(46%) and it is signiﬁcantly related with MACE (p¼ 0.001) and com-
plications during PCI (p¼0.001). The management of SCAD was
